211 related articles for article (PubMed ID: 22761740)
21. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium.
Tanfin Z; Serrano-Sanchez M; Leiber D
Cell Signal; 2011 Dec; 23(12):1997-2004. PubMed ID: 21803151
[TBL] [Abstract][Full Text] [Related]
22. Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.
Beach JA; Aspuria PJ; Cheon DJ; Lawrenson K; Agadjanian H; Walsh CS; Karlan BY; Orsulic S
Oncotarget; 2016 Jan; 7(4):4167-82. PubMed ID: 26716409
[TBL] [Abstract][Full Text] [Related]
23. Sphingosine-1-phosphate mediates epidermal growth factor-induced muscle satellite cell activation.
Nagata Y; Ohashi K; Wada E; Yuasa Y; Shiozuka M; Nonomura Y; Matsuda R
Exp Cell Res; 2014 Aug; 326(1):112-24. PubMed ID: 24960577
[TBL] [Abstract][Full Text] [Related]
24. Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation.
Ancellin N; Colmont C; Su J; Li Q; Mittereder N; Chae SS; Stefansson S; Liau G; Hla T
J Biol Chem; 2002 Feb; 277(8):6667-75. PubMed ID: 11741921
[TBL] [Abstract][Full Text] [Related]
25. Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1.
Li X; Stankovic M; Bonder CS; Hahn CN; Parsons M; Pitson SM; Xia P; Proia RL; Vadas MA; Gamble JR
Blood; 2008 Apr; 111(7):3489-97. PubMed ID: 18199826
[TBL] [Abstract][Full Text] [Related]
26. A novel mode of action of the putative sphingosine kinase inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation.
Ren S; Xin C; Pfeilschifter J; Huwiler A
Cell Physiol Biochem; 2010; 26(1):97-104. PubMed ID: 20502009
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors.
Bassi R; Anelli V; Giussani P; Tettamanti G; Viani P; Riboni L
Glia; 2006 Apr; 53(6):621-30. PubMed ID: 16470810
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases.
Kim JW; Kim YW; Inagaki Y; Hwang YA; Mitsutake S; Ryu YW; Lee WK; Ha HJ; Park CS; Igarashi Y
Bioorg Med Chem; 2005 May; 13(10):3475-85. PubMed ID: 15848761
[TBL] [Abstract][Full Text] [Related]
29. Signalling pathways involved in the direct effects of IGFBP-5 on breast epithelial cell attachment and survival.
McCaig C; Perks CM; Holly JM
J Cell Biochem; 2002; 84(4):784-94. PubMed ID: 11835403
[TBL] [Abstract][Full Text] [Related]
30. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2.
Takabe K; Kim RH; Allegood JC; Mitra P; Ramachandran S; Nagahashi M; Harikumar KB; Hait NC; Milstien S; Spiegel S
J Biol Chem; 2010 Apr; 285(14):10477-86. PubMed ID: 20110355
[TBL] [Abstract][Full Text] [Related]
31. Thiazolidinedione-dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cells.
Koch A; Völzke A; Wünsche C; Meyer zu Heringdorf D; Huwiler A; Pfeilschifter J
Br J Pharmacol; 2012 Jun; 166(3):1018-32. PubMed ID: 22221312
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression.
Ren S; Babelova A; Moreth K; Xin C; Eberhardt W; Doller A; Pavenstädt H; Schaefer L; Pfeilschifter J; Huwiler A
Kidney Int; 2009 Oct; 76(8):857-67. PubMed ID: 19657322
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine kinase activation mediates ischemic preconditioning in murine heart.
Jin ZQ; Goetzl EJ; Karliner JS
Circulation; 2004 Oct; 110(14):1980-9. PubMed ID: 15451787
[TBL] [Abstract][Full Text] [Related]
34. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells.
Duan HF; Wu CT; Lu Y; Wang H; Liu HJ; Zhang QW; Jia XX; Lu ZZ; Wang LS
Exp Cell Res; 2004 Aug; 298(2):593-601. PubMed ID: 15265705
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.
Schnitzer SE; Weigert A; Zhou J; Brüne B
Mol Cancer Res; 2009 Mar; 7(3):393-401. PubMed ID: 19240180
[TBL] [Abstract][Full Text] [Related]
36. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.
Maiti A; Takabe K; Hait NC
Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260
[TBL] [Abstract][Full Text] [Related]
37. Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration.
Döll F; Pfeilschifter J; Huwiler A
Endocr Relat Cancer; 2007 Jun; 14(2):325-35. PubMed ID: 17639048
[TBL] [Abstract][Full Text] [Related]
38. Sphingosine-1-phosphate: a potential therapeutic agent against human breast cancer.
Ling B; Chen L; Alcorn J; Ma B; Yang J
Invest New Drugs; 2011 Apr; 29(2):396-9. PubMed ID: 20041340
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the extracellular and intracellular actions of sphingosine 1-phosphate by using the p42/p44 mitogen-activated protein kinase cascade as a model.
Tolan D; Conway AM; Rakhit S; Pyne N; Pyne S
Cell Signal; 1999 May; 11(5):349-54. PubMed ID: 10376808
[TBL] [Abstract][Full Text] [Related]
40. FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells.
Berdyshev EV; Gorshkova I; Skobeleva A; Bittman R; Lu X; Dudek SM; Mirzapoiazova T; Garcia JG; Natarajan V
J Biol Chem; 2009 Feb; 284(9):5467-77. PubMed ID: 19119142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
